3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
2
Carcinoma
2
Thyroid Neoplasms
1
Teratoma, Ovarian
1
Struma Ovarii
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Iodine-131
21
lenvatinib
17
Magnetic Resonance Spectroscopy
17
trametinib
13
Sorafenib
13
Thyrotropin Alfa
12
pembrolizumab
11
dabrafenib
11
Thyroidectomy
10
Surgical Procedures, Operative
10
Thyroxine
9
Paclitaxel
9
vandetanib
8
selpercatinib
8
Sunitinib
7
Nivolumab
7
Fluorodeoxyglucose F18
7
cabozantinib
6
anlotinib
6
Everolimus
6
Biopsy
6
pazopanib
5
Vemurafenib
5
Triiodothyronine
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Iodine-124
5
Cyclophosphamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
DNA
×
Head & Neck
×
Clear all
NCT04053114
2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn